Radionecrosis after stereotactic radiotherapy for brain metastases

References

• Patel TR, Knisely JPS, Chiang VLS. Management of brain metastases: surgery, radiation, or both? Hematol Oncol Clin North Am. 2012;26(4):933–947.
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet Lond Engl. 2004;363(9422):1665–1672.
   PubMed Web of Science ®Google Scholar
• Sanghavi SN, Miranpuri SS, Chappell R, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys. 2001;51(2):426–434.
   PubMed Web of Science ®Google Scholar
• Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53(3):519–526.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. Jama. 2006;295(21):2483–2491.
   PubMed Web of Science ®Google Scholar
• Frazier JL, Batra S, Kapor S, et al. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival. Int J Radiat Oncol Biol Phys. 2010;76(5):1486–1492.
   PubMed Web of Science ®Google Scholar
• Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(2):134–141.
   PubMed Web of Science ®Google Scholar
• Soffietti R, Kocher M, Abacioglu UM, et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31(1):65–72.
   PubMed Web of Science ®Google Scholar
• Sahgal A, Aoyama H, Kocher M, et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015;91(4):710–717.
   PubMed Web of Science ®Google Scholar
• Inoue HK, Seto K-I, Nozaki A, et al. Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14). J Radiat Res (Tokyo). 2013;54(4):727–735.
   PubMed Web of Science ®Google Scholar
• Minniti G, D’Angelillo RM, Scaringi C, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 2014;117(2):295–301.
   PubMed Web of Science ®Google Scholar
• Telera S, Fabi A, Pace A, et al. Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease. J Neurooncol. 2013;113(2):313–325.
   PubMed Web of Science ®Google Scholar
• Sneed PK, Mendez J, Vemer-Van Den Hoek JGM, et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123(2):373–386.
   PubMed Web of Science ®Google Scholar
• Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurologist. 2003;9(4):180–188.
   PubMed Web of Science ®Google Scholar
• Kohutek ZA, Yamada Y, Chan TA, et al. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. J Neurooncol. 2015;125(1):149–156.
   PubMed Web of Science ®Google Scholar
• Gonzalez J, Kumar AJ, Conrad CA, et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007;67(2):323–326.
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Lin NU, Claus EB, et al. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors. Cancer. 2012;118(8):2014–2020.
   PubMed Web of Science ®Google Scholar
• McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol. 2004;68(1):41–47.
   PubMed Web of Science ®Google Scholar
• Torcuator R, Zuniga R, Mohan YS, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009;94(1):63–68.
   PubMed Web of Science ®Google Scholar
• Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487–1495.
   PubMed Web of Science ®Google Scholar
• Boothe D, Young R, Yamada Y, et al. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro-Oncol. 2013;15(9):1257–1263.
   PubMed Web of Science ®Google Scholar
• Minniti G, Scaringi C, Paolini S, et al. Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol. 2016;126(1):91–97.
   PubMed Web of Science ®Google Scholar
• Deibert CP, Ahluwalia MS, Sheehan JP, et al. Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol. 2013;115(2):217–223.
   PubMed Web of Science ®Google Scholar
• Furuse M, Nonoguchi N, Kawabata S, et al. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol. 2013;43(3):337–341.
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncology [Internet]. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#cns.
   Google Scholar
• Dequesada IM, Quisling RG, Yachnis A, et al. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery. 2008;63(5):898–903; discussion 904.
   PubMed Web of Science ®Google Scholar
• Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010;28(1):217–234.
   PubMed Web of Science ®Google Scholar
• Barajas RF, Chang JS, Sneed PK, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2009;30(2):367–372.
   PubMed Web of Science ®Google Scholar
• Sundgren PC. MR spectroscopy in radiation injury. AJNR Am J Neuroradiol. 2009;30(8):1469–1476.
   PubMed Web of Science ®Google Scholar
• Ross DA, Sandler HM, Balter JM, et al. Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol. 2002;56(2):175–181.
   PubMed Web of Science ®Google Scholar
• Nichol A, Ma R, Hsu F, et al. Volumetric radiosurgery for 1 to 10 brain metastases: a multicenter, single-arm, phase 2 study. Int J Radiat Oncol Biol Phys. 2016;94(2):312–321.
   PubMed Web of Science ®Google Scholar
• Yoshii Y. Pathological review of late cerebral radionecrosis. Brain Tumor Pathol. 2008;25(2):51–58.
   PubMed Web of Science ®Google Scholar
• Cheng KM, Chan CM, Fu YT, et al. Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature. J Neurooncol. 2001;51(2):143–150.
   PubMed Web of Science ®Google Scholar
• Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin. 2003;21(1):249–277.
   PubMed Web of Science ®Google Scholar
• Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84(5):1470–1478.
   PubMed Web of Science ®Google Scholar
• Nonoguchi N, Miyatake S-I, Fukumoto M, et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol. 2011;105(2):423–431.
   PubMed Web of Science ®Google Scholar
• Kim JH, Chung YG, Kim CY, et al. Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy. J Korean Med Sci. 2004;19(6):879–886.
   PubMed Web of Science ®Google Scholar
• Flickinger JC, Lunsford LD, Kondziolka D, et al. Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys. 1992;23(1):19–26.
   PubMed Web of Science ®Google Scholar
• Minniti G, Clarke E, Lanzetta G, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol Lond Engl. 2011;6:48.
   PubMed Web of Science ®Google Scholar
• Blonigen BJ, Steinmetz RD, Levin L, et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77(4):996–1001.
   PubMed Web of Science ®Google Scholar
• Tamari K, Suzuki O, Hashimoto N, et al. Treatment outcomes using CyberKnife for brain metastases from lung cancer. J Radiat Res (Tokyo). 2015;56(1):151–158.
   PubMed Web of Science ®Google Scholar
• Voges J, Treuer H, Sturm V, et al. Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys. 1996;36(5):1055–1063.
   PubMed Web of Science ®Google Scholar
• Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291–298.
   PubMed Web of Science ®Google Scholar
• Roberge D, Parney I, Brown PD. Radiosurgery to the postoperative surgical cavity: who needs evidence? Int J Radiat Oncol Biol Phys. 2012;83(2):486–493.
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Yu C, Giannotta SL, et al. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg. 2002;97(5 Suppl):499–506.
   PubMed Web of Science ®Google Scholar
• Korytko T, Radivoyevitch T, Colussi V, et al. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 2006;64(2):419–424.
   PubMed Web of Science ®Google Scholar
• Tye K, Engelhard HH, Slavin KV, et al. An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol. 2014;117(2):321–327.
   PubMed Web of Science ®Google Scholar
• Maldaun MVC, Aguiar PHP, Lang F, et al. Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev. 2008;31(1):1–8; discussion 8–9.
   PubMed Web of Science ®Google Scholar
• Swinson BM, Friedman WA. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. Neurosurgery. 2008;62(5):1018–1031;discussion 1031–1032.
   PubMed Web of Science ®Google Scholar
• Bindal RK, Sawaya R, Leavens ME, et al. Reoperation for recurrent metastatic brain tumors. J Neurosurg. 1995;83(4):600–604.
   PubMed Web of Science ®Google Scholar
• Molenaar R, Wiggenraad R, Verbeek-de Kanter A, et al. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg. 2009;23(2):170–178.
   PubMed Web of Science ®Google Scholar
• Foroughi M, Kemeny AA, Lehecka M, et al. Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations–case analysis and literature review. Acta Neurochir (Wien). 2010;152(5):803–815.
   PubMed Web of Science ®Google Scholar
• Inoue HK, Sato H, Seto K, et al. Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis. J Radiat Res (Tokyo). 2014;55(2):334–342.
   PubMed Web of Science ®Google Scholar
• Hoefnagels FWA, Lagerwaard FJ, Sanchez E, et al. Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol. 2009;256(6):878–887.
   PubMed Web of Science ®Google Scholar
• Greene-Schloesser D, Robbins ME, Peiffer AM, et al. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.
   PubMedGoogle Scholar
• Ruben JD, Dally M, Bailey M, et al. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65(2):499–508.
   PubMed Web of Science ®Google Scholar
• Carangelo B, Cerillo A, Mariottini A, et al. Therapeutic strategy of late cerebral radionecrosis. A retrospective study of 21 cases. J Neurosurg Sci. 2010;54(1):21–28.
   PubMed Web of Science ®Google Scholar
• Minniti G, Esposito V, Clarke E, et al. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys. 2013;86(4):623–629.
   PubMed Web of Science ®Google Scholar
• Ahmed KA, Freilich JM, Abuodeh Y, et al. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases. J Neurooncol. 2014;118(1):179–186.
   PubMed Web of Science ®Google Scholar
• Rajakesari S, Arvold ND, Jimenez RB, et al. Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014;120(2):339–346.
   PubMed Web of Science ®Google Scholar
• Manon R, O’Neill A, Knisely J, et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an eastern cooperative oncology group study (E 6397). J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(34):8870–8876.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45(2):427–434.
   PubMed Web of Science ®Google Scholar
• Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol Off J Am Soc Clin Oncol. 1998;16(11):3563–3569.
   PubMed Web of Science ®Google Scholar
• Lutterbach J. Commentary on the article by Winking M, et al. Influence of postoperative radiation therapy of cerebral metastases on survival time and disease related living conditions. Zentralbl Neurochir. 2003;64(2):90. Author reply 91–92.
   PubMedGoogle Scholar
• Kondziolka D, Niranjan A, Flickinger JC, et al. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol. 2005;28(2):173–179.
   PubMed Web of Science ®Google Scholar
• Williams BJ, Suki D, Fox BD, et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg. 2009;111(3):439–448.
   PubMed Web of Science ®Google Scholar
• Kano H, Kondziolka D, Zorro O, et al. The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg. 2009;111(4):825–831.
   PubMed Web of Science ®Google Scholar
• Schöggl A, Kitz K, Reddy M, et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien). 2000;142(6):621–626.
   PubMed Web of Science ®Google Scholar
• Marks JE, Baglan RJ, Prassad SC, et al. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys. 1981;7(2):243–252.
   PubMed Web of Science ®Google Scholar
• Truong MT, St Clair EG, Donahue BR, et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery. 2006;59(1):86–97; discussion 86–97.
   PubMed Web of Science ®Google Scholar
• Butler JM, Rapp SR, Shaw EG. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol. 2006;7(6):517–523.
   PubMedGoogle Scholar
• Chao ST, Ahluwalia MS, Barnett GH, et al. Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys. 2013;87(3):449–457.
   PubMed Web of Science ®Google Scholar
• Chin LS, Ma L, DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg. 2001;94(6):899–904.
   PubMed Web of Science ®Google Scholar
• Sanborn MR, Danish SF, Rosenfeld MR, et al. Treatment of steroid refractory, Gamma knife related radiation necrosis with bevacizumab: case report and review of the literature. Clin Neurol Neurosurg. 2011;113(9):798–802.
   PubMed Web of Science ®Google Scholar
• Raimbault A, Cazals X, Lauvin M-A, et al. Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. Diagn Interv Imaging. 2014;95(10):985–1000.
   PubMed Web of Science ®Google Scholar
• Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology. 2000;217(2):377–384.
   PubMed Web of Science ®Google Scholar
• Mullins ME, Barest GD, Schaefer PW, et al. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol. 2005;26(8):1967–1972.
   PubMed Web of Science ®Google Scholar
• Hatzoglou V, Ulaner GA, Zhang Z, et al. Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients. Clin Imaging. 2013;37(3):451–457.
   PubMed Web of Science ®Google Scholar
• Ricci PE, Karis JP, Heiserman JE, et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol. 1998;19(3):407–413.
   PubMed Web of Science ®Google Scholar
• Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol. 1988;150(1):189–197.
   PubMed Web of Science ®Google Scholar
• Cicone F, Minniti G, Romano A, et al. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging. 2015;42(1):103–111.
   PubMed Web of Science ®Google Scholar
• Miyashita M, Miyatake S-I, Imahori Y, et al. Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol. 2008;89(2):239–246.
   PubMed Web of Science ®Google Scholar
• Lai G, Mahadevan A, Hackney D, et al. Diagnostic accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery. AJNR Am J Neuroradiol. 2015;36(12):2250–2255.
   PubMed Web of Science ®Google Scholar
• Belohlávek O, Simonová G, Kantorová I, et al. Brain metastases after stereotactic radiosurgery using the Leksell Gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med Mol Imaging. 2003;30(1):96–100.
   PubMed Web of Science ®Google Scholar
• Jain R, Narang J, Sundgren PM, et al. Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol. 2010;100(1):17–29.
   PubMed Web of Science ®Google Scholar
• Schüttrumpf LH, Niyazi M, Nachbichler SB, et al. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases. Radiat Oncol Lond Engl. 2014;9:105.
   PubMed Web of Science ®Google Scholar
• Nedzi LA, Kooy H, Alexander E, et al. Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys. 1991;21(3):591–599.
   PubMed Web of Science ®Google Scholar
• Flickinger JC, Kondziolka D, Lunsford LD. Dose selection in stereotactic radiosurgery. Neurosurg Clin N Am. 1999;10(2):271–280.
   PubMed Web of Science ®Google Scholar
• Ohtakara K, Hayashi S, Nakayama N, et al. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases. J Neurooncol. 2012;108(1):201–209.
   PubMed Web of Science ®Google Scholar
• Flickinger JC, Kondziolka D, Pollock BE, et al. Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys. 1997;38(3):485–490.
   PubMed Web of Science ®Google Scholar
• Lawrence YR, Li XA, El Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S20–27.
   PubMed Web of Science ®Google Scholar
• Ahmed KA, Stallworth DG, Kim Y, et al. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2016;27(3):434–441.
   PubMed Web of Science ®Google Scholar
• Kiess AP, Wolchok JD, Barker CA, et al. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys. 2015;92(2):368–375.
   PubMed Web of Science ®Google Scholar
• Patel KR, Shoukat S, Oliver DE, et al. Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases. Am J Clin Oncol. 2015. [Epub ahead of print]
   Web of Science ®Google Scholar
• Patel BG, Ahmed KA, Johnstone PAS, et al. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res. 2016. [Epub ahead of print]
   Google Scholar
• Dhermain F, Deutsch E. Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both? Ann Oncol Off J Eur Soc Med Oncol ESMO. 2016;27(3):371–372.
   PubMed Web of Science ®Google Scholar
• Mut M. Surgical treatment of brain metastasis: a review. Clin Neurol Neurosurg. 2012;114(1):1–8.
   PubMed Web of Science ®Google Scholar
• Vecil GG, Suki D, Maldaun MVC, et al. Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg. 2005;102(2):209–215.
   PubMed Web of Science ®Google Scholar
• Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994;44(11):2020–2027.
   PubMed Web of Science ®Google Scholar
• Chuba PJ, Aronin P, Bhambhani K, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer. 1997;80(10):2005–2012.
   PubMed Web of Science ®Google Scholar
• Mathews MS, Linskey ME, Hasso AN, et al. The effect of bevacizumab (Avastin) on neuroimaging of brain metastases. Surg Neurol. 2008;70(6):649–652; discussion 653.
   PubMedGoogle Scholar
• Rahmathulla G, Recinos PF, Valerio JE, et al. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg. 2012;90(3):192–200.
   PubMed Web of Science ®Google Scholar
• Furuse M, Kawabata S, Kuroiwa T, et al. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol. 2011;102(3):471–475.
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan L, Sheng X, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res. 2012;17:25.
   PubMed Web of Science ®Google Scholar
• Benoit A, Ducray F, Cartalat-Carel S, et al. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis. J Neurol. 2011;258(2):328–329.
   PubMed Web of Science ®Google Scholar
• Gronier S, Bourg V, Frenay M, et al. Bevacizumab for the treatment of cerebral radionecrosis. Rev Neurol (Paris). 2011;167(4):331–336.
   PubMed Web of Science ®Google Scholar
• Williams BJ, Park DM, Sheehan JP. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg. 2012;116(5):972–977.
   PubMed Web of Science ®Google Scholar
• Matuschek C, Bölke E, Nawatny J, et al. Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol Organ Dtsch Röntgenges Al. 2011;187(2):135–139.
   PubMed Web of Science ®Google Scholar
• Wong ET, Huberman M, Lu X-Q, et al. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol. 2008;26(34):5649–5650.
   PubMed Web of Science ®Google Scholar